Sort   by:  
 Page size 
UnknownEfficacy and Safety Outcomes in Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab Because of Adverse Events: A Pooled Analysis of Randomized Phase II and III Trials.
Not available
S-EPMC5791828 | biostudies-literature
TranscriptomicsMetastatic potential is determined early in synovial sarcoma development and reflected by tumor molecular features [transcriptome]
Synovial sarcoma (SynSa) is an aggressive mesenchymal tumor, comprising approximately 10% of all soft tissue sarcomas. Over half of SynSa patients develop metastasis or local recurrence, but the underlying molecular mechanisms of the aggressive clinical behavior remain poorly characterized. Sixty f...
ORGANISM(S): Homo sapiens 
2014-07-31 | E-GEOD-54187 | biostudies-arrayexpress
TranscriptomicsMetastatic potential is determined early in synovial sarcoma development and reflected by tumor molecular features [aCGH]
Synovial sarcoma (SynSa) is an aggressive mesenchymal tumor, comprising approximately 10% of all soft tissue sarcomas. Over half of SynSa patients develop metastasis or local recurrence, but the underlying molecular mechanisms of the aggressive clinical behavior remain poorly characterized. Sixty f...
ORGANISM(S): Homo sapiens 
2014-07-31 | E-GEOD-54183 | biostudies-arrayexpress
ProteomicsPrognostic value of molecular intratumor heterogeneity in primary oral cancer and its lymph node metastases assessed by mass spectrometry imaging
Different aspects of intra-tumor heterogeneity (ITH), which are associated with development of cancer and its response to treatment, have postulated prognostic value. Here we searched for the potential association between phenotypic ITH analyzed by mass spectrometry imaging (MSI) and the prognosis o...
ORGANISM(S): Homo sapiens (Human) 
2022-10-13 | PXD034958 | Pride
Cancer prognosis  head and neck squamous cell carcinoma  intratumor heterogeneity  long-term outcome  mass spectrometry imaging  tumor microenvironment 
Sort   by:  
 Page size